Mishal Khan: Long-Term Mortality Trends and Demographic Disparities in Patients With PE and AF
Mishal Khan, President VFAHT-FMC at Infection Prevention and Control Foundation and Vice President FMC LC at IFMSA-Pakistan, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Journal of Arrhythmia, adding:
“Excited to share our latest publication in the Journal of Arrhythmia:
‘Trends and Disparities in Mortality due to Pulmonary Embolism Among Adults With Atrial Fibrillation From 1999 to 2020: Insights From the CDC WONDER Database’
Using over two decades of national mortality data, our study is among the first to characterize long-term mortality trends and demographic disparities in patients with pulmonary embolism (PE) and coexisting atrial fibrillation (AF).
We found that PE-related mortality in patients with AF has risen significantly since 2009, with disproportionately higher mortality among men, rural populations, and certain geographic regions.
These findings highlight important inequities in cardiovascular outcomes and identify populations that may benefit from targeted prevention and healthcare interventions.
Beyond describing trends, our work provides a foundation for future research exploring the drivers of these disparities, including anticoagulation access and adherence, healthcare infrastructure, and socioeconomic factors.
It also supports the need for policies that strengthen AF screening, improve access to specialized cardiovascular care in underserved regions, and expand telemedicine-based anticoagulation management.
Grateful to all my co-authors for their incredible collaboration throughout this project.”
Title: Trends and Disparities in Mortality due to Pulmonary Embolism Among Adults With Atrial Fibrillation From 1999 to 2020: Insights From the CDC WONDER Database
Authors: Eeman Ahmad, Mishal Khan, Muhammad Ans, Hoor Ul Ain, Ahmad Qaisar, Shahzaib Ahmed, Olivier Uwishema, Ibrahim Nagmeldin Hassan, Muhammad Saad, Abbas Hayat Mallick, M Chadi Alraies

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering